A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Mersana Therapeutics Inc’s current trading price is -68.47% away from its 52-week high, while its distance from the 52-week low is 62.30%. The stock’s price range for this time frame has been between $1.22 and $6.28. The trading volume of the company’s shares in the Healthcare reached around 1.01 million for the day, which was evidently lower than the average daily volume of 1.02 million over the last three months.
In terms of market performance, Mersana Therapeutics Inc had a somewhat regular. The highest value for the stock in the past year was $6.28 on 03/11/24, while the lowest value was $1.22 on 08/14/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Mersana Therapeutics Inc (MRSN) has experienced a quarterly rise of 26.92% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 244.59M and boasts a workforce of 123 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.89, with a change in price of +0.12. Similarly, Mersana Therapeutics Inc recorded 1,095,431 in trading volume during the last 100 days, posting a change of +6.45%.
How MRSN’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for MRSN stands at 30.00. Similarly, the long-term debt-to-equity ratio is also 15.51.
MRSN Stock Stochastic Average
The raw stochastic average for Mersana Therapeutics Inc over the last 50 days is presently at 21.98%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 17.48%. Further, the company’s Stochastic %K and %D values for the last 20 days were 33.01% and 35.71%, respectively.
MRSN Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -14.66%. However, over the past six months, we’ve seen a stronger performance of -19.84%. The price of MRSN leaped by -3.88% over the last 30 days. And in the last five days, it has fallen by -21.43%.
